Ira Sohn
Since 1996, the world-renowned Sohn Investment Conference has been the premier investment forum, bringing together the world's savviest investors to share fresh insights and strategies in support of pediatric cancer research and treatment.
Wall Street's best and brightest investors participate in this unique, 'must attend' event to share their expertise with an audience of more than 3,000 people, comprised of portfolio managers, asset allocators and private investors. Most speakers manage large proprietary investment portfolios that have outperformed the market for many years and do not share their insights in any public forum, but they volunteer their time to the Conference for the benefit of the Foundation. All contributions support the Foundation's mission to support pediatric research and care.
View Older Stories View More Recent Stories
-
Nixxy Expects to Complete an Undisclosed Acquisition by Month-End, Withdraws BTC Financing
-
Introducing Lumio: Unlocking Potential for Professional Services in the AI Era
-
Sohn Montreal Investment Conference Announces Speaker Lineup for Inaugural May 2025 Event
-
Form 13F-HR B. Metzler seel. Sohn & For: Dec 31
-
Form 4 Altimmune, Inc. For: Feb 06 Filed by: Sohn Catherine A.
-
Form 3 Maze Therapeutics, Inc. For: Jan 30 Filed by: Sohn Catherine A.
-
US economy resilient despite moderation in growth in fourth quarter
-
Ati Motors Raises $20M Series B for Global Expansion of its AI-Powered Robotics Workforce
-
US issuers REX Advisers, Osprey seek approval to launch Trump meme coin ETF
-
Celebrating 30 Years of Impact: The Sohn Conference Foundation Announces Speaker Lineup for the 2025 New York Sohn Investment Conference
-
Capital Group launches its first small and mid-cap ETF in US market
-
AllerVie Health Announces Formation of AllerVie Advisory Council and Addition to Board of Directors
-
Cryptoverse: Next wave of US crypto ETFs already in the pipeline
-
Aura Intelligence 2025 Report: The Skills Employers Can't Hire Fast Enough
-
Nixxy (NIXX) Appoints Debra Chen Volpone as CEO and Board Member
-
Nixxy Appoints Capital Markets Veteran Debra Chen Volpone to CEO and Board Member
-
MBK Partners and Young Poong to Restore Korea Zinc's Shareholder Value through Governance Reform
-
Direxion launches new leveraged ETFs tied to Palantir, Berkshire Hathaway
-
Chungnam National University Researchers Uncover Breakthrough in Copper-Zinc Electrodes for Electrochemical CO₂ Reduction
-
Dongguk University Develops Gel-Based Stretchable Triboelectric Nanogenerators for Wearable Technology
-
US job market bounces back from impact of strikes, hurricanes
-
Elf Beauty stock slides after Muddy Waters says it has shorted its shares
-
e.l.f. Beauty, Inc. (ELF) Mentioned Cautiously at Muddy Waters
-
Gatemore Capital Management presents at Sohn Investment Conference
-
Turpaz acquires German flavor company Schumann
-
McCune Law Group Suit Alleging Ford Motors Fraudulently Concealed Popular Truck's "Death Wobble" Defect to Move Forward
-
Form 13F-HR B. Metzler seel. Sohn & For: Sep 30
-
Form 13F-HR B. Metzler seel. Sohn & For: Sep 30
-
Volastra Therapeutics Announces the Appointment of Co-Founder Samuel Bakhoum, M.D., Ph.D., as Chief Scientific Officer
-
15th Annual Sohn San Francisco Investment Conference Adds to its Speaker Lineup; Convenes Leading Investors in Support of Local Nonprofits
-
Inaugural Sohn Montreal Investment Conference to Convene Leading Investors and Allocators on May 28, 2025
-
Form 4 Altimmune, Inc. For: Sep 26 Filed by: Sohn Catherine A.
-
The Pershing Square Foundation’s MIND (Maximizing Innovation in Neuroscience Discovery) Prize Is Now Accepting Applications for 2025
-
Helpt Appoints Amy Luby as Chief Revenue Officer Amidst Period of Accelerated Growth
-
15th Annual Sohn San Francisco Investment Conference to Convene Leading Investors and Support Local Nonprofits
-
US bond ETF launches up 50% from year-ago levels
-
The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for its 2025 Prize for Rising Stars in Cancer Research
-
BenevolentAI Interim Results for the Six Months Ended 30 June 2024
-
Samsung senior adviser Young Sohn to rejoin Arm's board
-
Arm Holdings (ARM) Appoints Young Sohn to its Board
-
Arm Announces Appointment of Young Sohn to its Board of Directors
-
U.S. stocks tumble as September starts, investors cool on chips
-
Nvidia suffers record $279 billion loss in market value as Wall St drops
-
Form N-PX B. Metzler seel. Sohn & For: Jun 30
-
Form 13F-HR B. Metzler seel. Sohn & For: Jun 30
-
ATA Creativity Global Reports Second Quarter 2024 Financial Results
-
Sauer Compressors USA Names New Business Development Managers
-
Form 144 Jazz Pharmaceuticals Filed by: Sohn Catherine A.
-
ATA Creativity Global Schedules 2024 Second Quarter Financial Results Release and Conference Call
-
NeuroBo Pharmaceuticals (NRBO) Announces Exclusive License Agreement with MThera Pharma for NB-01

